Risk of malaria in visitors to the Kruger National Park, South Africa.

BACKGROUND The risk of malaria to visitors to South Africa's nature reserves is unknown. Current recommendations for travelers are based on malaria incidence rates in local communities. These rates may well overestimate travelers' malaria risk and lead to unnecessary use of antimalarial prophylaxis with associated drug-related adverse events. This study investigated the incidence of malaria in visitors to South Africa's Kruger National Park (KNP). METHODS Postal questionnaires were sent to the cohort of visitors staying in the KNP during April 1996, 6 to 8 weeks after they returned to their homes. Nonrespondents received duplicate questionnaires 8 weeks later. Responses from 3267 groups, representing 11,107 visitors (56. 8%) allowed determination of the malaria attack rate in this group of travelers and assessment of associations between malaria risk and a number of factors, including type of accommodation used during the visit; duration of stay; use of chemoprophylaxis; and use of personal protection measures. All travelers indicating that they had suffered an episode of malaria following their visit were telephonically contacted and their health providers traced to determine the basis of diagnosis and clinical outcome. RESULTS One clinically suspected and four confirmed cases of Plasmodium falciparum malaria among the visitors suggest a low attack rate of 4. 5 cases per 10,000 visitors during April, the highest risk month for malaria in South Africa. No association was found between malaria risk and accommodation type, duration of stay, use and type of chemoprophylaxis, and use and number of personal protection measures. CONCLUSIONS These findings confirm the importance of careful assessment of local malaria risk before individualized advice is provided to travelers.

[1]  M. Marinker The doctor's role in prescribing. , 1973, The Journal of the Royal College of General Practitioners.

[2]  P. Phillips-Howard,et al.  WHAT DO TRAVELLERS KNOW ABOUT MALARIA? , 1989, The Lancet.

[3]  P. Phillips-Howard,et al.  Malaria incidence and prevention among European and North American travellers to Kenya. , 1990, Bulletin of the World Health Organization.

[4]  Recommendations for the prevention of malaria among travelers. , 1990, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[5]  R. Steffen,et al.  Travel medicine--prevention based on epidemiological data. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  Robert Steffen,et al.  3. Travel medicine—prevention based on epidemiological data , 1991 .

[7]  D. Hill,et al.  Pre-travel health, immunization status, and demographics of travel to the developing world for individuals visiting a travel medicine service. , 1991, The American journal of tropical medicine and hygiene.

[8]  Alimuddin Zumla,et al.  Chloroquine and proguanil prophylaxis in travellers to Kenya , 1992, The Lancet.

[9]  T. Usherwood Reviews, Notes, and Listings: International Travel and Health: Vaccination Requirements and Health Advice , 1989, Annals of Internal Medicine.

[10]  D. Bradley,et al.  Malaria prophylaxis: guidelines for travellers from Britain. Malaria Reference Laboratory of the Public Health Laboratory Service, London. , 1995, BMJ.

[11]  D. Bradley,et al.  The risk of malaria in travellers to Thailand. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[12]  P. Barrett,et al.  Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers , 1996, BMJ.

[13]  S. Dollow Risk-benefit ratio must be taken into account , 1996, BMJ.

[14]  J. Patz,et al.  Global climate change and emerging infectious diseases. , 1996, JAMA.